Helen Of Troy Limited (HELE)
NASDAQ:HELE
Want to see HELE full AI Analyst Report?
Top Page
Helen Of Troy
(NASDAQ:HELE)
Select Model
Select Model
Rating:55Neutral
Price Target:
$24.50
▲(29.90% Upside)
Action:ReiteratedDate:04/24/26
Overall score is held back primarily by sharply deteriorated TTM profitability and multi-year revenue pressure, partially offset by positive free cash flow and balance-sheet actions discussed alongside guidance. Technicals show strong upward momentum, but overbought indicators reduce the technical score. Valuation is difficult to support given the negative P/E and no dividend yield provided, while the earnings call adds moderate support via FY2027 EBITDA/EPS/FCF guidance and operational tariff-mitigation progress tempered by near-term margin and sales headwinds.
Positive Factors
Free Cash Flow Generation
Sustained positive operating and free cash flow (~$171M TTM) provides durable internal funding for working capital, debt reduction, and targeted capex. Over the next 2–6 months this cash generation cushions the business against earnings volatility and supports execution of the multi‑year turnaround plan.
Negative Factors
Severe Profitability Deterioration
A dramatic swing to a ~-44% net margin reflects large operating or non‑cash charges overwhelming gross profit. Persistent negative profitability undermines return generation, erodes equity, and constrains the company's ability to invest in growth or absorb shocks until operating leverage is restored and structural cost issues are resolved.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Generation
Sustained positive operating and free cash flow (~$171M TTM) provides durable internal funding for working capital, debt reduction, and targeted capex. Over the next 2–6 months this cash generation cushions the business against earnings volatility and supports execution of the multi‑year turnaround plan.
Read all positive factors
Helen Of Troy (HELE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$556.56M
Dividend YieldN/A
Average Volume (3M)551.58K
Price to Earnings (P/E)―
Beta (1Y)1.08
Revenue Growth-5.93%
EPS Growth-823.81%
CountryUS
Employees1,883
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-39.15
Shares Outstanding23,257,706
10 Day Avg. Volume565,475
30 Day Avg. Volume551,576
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.51
Price to Sales (P/S)0.23
P/FCF Ratio3.08
Enterprise Value/Market Cap2.46
Enterprise Value/Revenue0.77
Enterprise Value/Gross Profit1.68
Enterprise Value/Ebitda-4.35
Forecast
1Y Price Target
$24.00Price Target Upside27.25% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)3.27
Revenue Forecast (FY)$1.77B
Helen Of Troy Business Overview & Revenue Model
Company Description
Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty...
How the Company Makes Money
Helen of Troy primarily makes money by selling branded consumer products to retail customers (e.g., mass retailers, specialty retailers, and e-commerce channels) and, to a lesser extent, through direct-to-consumer sales via brand websites. Revenue...
Helen Of Troy Key Performance Indicators (KPIs)
Helen Of Troy Earnings Call Summary
Earnings Call Date:Apr 23, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Jul 09, 2026
Earnings Call Sentiment Neutral
The call balances concrete operational progress (inventory discipline, debt paydown, tariff mitigation, strong performance from select brands and international growth, and clear FY2027 targets) against meaningful near‑term challenges (year‑over‑year revenue declines in key segments, significant margin compression, tariff cash outflows, and macro/commodity/freight uncertainty). Management emphasizes a multi‑year roadmap focused on brand investment, supply‑chain diversification, and consumer‑centric execution, but the near‑term financial picture is cautious and lumpy.Positive Updates
Q4 Sales Performance vs. Expectations
Consolidated Q4 sales decreased 3.3% year‑over‑year but were favorable to the company’s outlook and described as exceeding expectations.
Negative Updates
Year‑over‑Year Revenue Declines in Segments
Home & Outdoor sales declined 1.5% and Beauty & Wellness sales declined 4.7% in Q4 (Beauty & Wellness decline included ~2.8 percentage points driven by tariff‑related disruption).
Read all updates
Q4-2026 Updates
Positive
Negative
Q4 Sales Performance vs. Expectations
Consolidated Q4 sales decreased 3.3% year‑over‑year but were favorable to the company’s outlook and described as exceeding expectations.
Read all positive updates
Company Guidance
Helen of Troy guided Fiscal 2027 net sales of $1.751–$1.822 billion (Home & Outdoor $854–$882M; Beauty & Wellness $897–$940M), adjusted EBITDA of $190–$197M (implying +2.1% to +6.3% YoY), adjusted EPS of $3.25–$3.75 and free cash flow of $85–$100M, noting a front‑loaded cadence (midpoint: slightly positive H1 sales, slightly negative H2; roughly 15% of annual adjusted EPS in H1 and breakeven EPS in Q1). Guidance assumes tariffs in place as of April 2026, interest expense of $47–$49M, an adjusted tax rate of 25%–27%, capex of $28–$32M, FX flat, and a deliberate ~40 bps increase in growth investment; management expects net leverage of ~3.2x or lower by year‑end. Key balance sheet and operational context included FY26 inventory of $456M (flat YoY, with $34M incremental tariff cost), FY26 free cash flow $132M despite $72M of tariff/diversification cash outflows, year‑end debt $781M (net leverage 3.87x) with $112M of Q4 debt paydown plus ~$78M proceeds from the Southaven sale; the company reduced gross tariff impact from $51M to < $30M net on operating income in FY26, can dual‑source ~45% of volume today (target ~55% in FY27) and aims to cut COGS exposure to China tariffs to <20% by end of FY27.Helen Of Troy Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
42
Neutral
Cash Flow
63
Positive
| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.79B | 1.91B | 2.01B | 2.07B | 2.22B |
| Gross Profit | 815.69M | 914.41M | 948.66M | 899.35M | 953.19M |
| EBITDA | -727.80M | 268.61M | 301.32M | 286.94M | 310.88M |
| Net Income | -898.98M | 123.75M | 168.59M | 143.27M | 223.76M |
Balance Sheet | |||||
| Total Assets | 2.12B | 3.13B | 2.84B | 2.91B | 2.82B |
| Cash, Cash Equivalents and Short-Term Investments | 18.89M | 18.87M | 18.50M | 29.07M | 33.38M |
| Total Debt | 833.70M | 956.84M | 702.93M | 977.08M | 856.96M |
| Total Liabilities | 1.32B | 1.45B | 1.20B | 1.42B | 1.50B |
| Stockholders Equity | 798.20M | 1.68B | 1.64B | 1.49B | 1.33B |
Cash Flow | |||||
| Free Cash Flow | 131.91M | 83.14M | 269.42M | 33.38M | 62.78M |
| Operating Cash Flow | 171.14M | 113.21M | 306.07M | 208.24M | 140.82M |
| Investing Cash Flow | -34.43M | -263.09M | 5.45M | -319.33M | -438.91M |
| Financing Cash Flow | -136.69M | 150.25M | -322.09M | 106.78M | 286.35M |
Helen Of Troy Technical Analysis
Positive
18.86
Price Trends
16.62
Positive
18.13
Positive
20.45
Negative
Market Momentum
0.46
Negative
72.93
Negative
94.25
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HELE, the sentiment is Positive. The current price of 18.86 is above the 20-day moving average (MA) of 15.81, above the 50-day MA of 16.62, and below the 200-day MA of 20.45, indicating a neutral trend. The MACD of 0.46 indicates Negative momentum. The RSI at 72.93 is Negative, neither overbought nor oversold. The STOCH value of 94.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HELE.
Helen Of Troy Risk Analysis
Helen Of Troy disclosed 28 risk factors in its most recent earnings report. Helen Of Troy reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Helen Of Troy Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $33.52M | 13.44 | 19.09% | 9.81% | -13.43% | -35.23% | |
68 Neutral | $1.92B | 12.42 | 5.52% | 3.15% | -6.25% | 4.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | $556.56M | -0.45 | -94.52% | ― | -5.93% | -823.81% | |
55 Neutral | $353.58M | 2.96 | 20.36% | 2.39% | -14.26% | ― | |
52 Neutral | $1.05B | -3.02 | -2.50% | 3.51% | -3.36% | -145.55% | |
48 Neutral | $111.88M | -5.47 | -15.42% | ― | -10.01% | 68.05% |
* Consumer Defensive Sector Average
HELE
Helen Of Troy
23.93
-1.36
-5.38%
NUS
Nu Skin
7.19
1.42
24.52%
SPB
Spectrum Brands Holdings
82.96
20.03
31.83%
UG
United-Guardian
7.30
-0.25
-3.29%
EPC
Edgewell Personal Care
22.56
-7.24
-24.31%
SKIN
Beauty Health
0.86
-0.20
-18.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.